Works matching IS 00126667 AND DT 2025 AND VI 85 AND IP 2
Results: 12
Correction: Fulzerasib: First Approval: Correction: Fulzerasib: First Approval: Y.N. Lamb.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Current and Emerging Therapies for Lysosomal Storage Disorders: Treatment of Lysosomal Storage Disorders: D.A.A. Lastoria et al.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 171, doi. 10.1007/s40265-025-02145-5
- By:
- Publication type:
- Article
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer: CDK4/6 Inhibitors in Early Breast Cancer: E. V. Klocker et al.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 149, doi. 10.1007/s40265-024-02144-y
- By:
- Publication type:
- Article
Comment on: "The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab": Comment on: "The Utilization of the Accelerated Approval...: R. Giusti.
- Published in:
- 2025
- By:
- Publication type:
- Letter to the Editor
Inavolisib: First Approval: Inavolisib: First Approval: H. A. Blair.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 271, doi. 10.1007/s40265-024-02136-y
- By:
- Publication type:
- Article
Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis: Complicated Gram-Positive Bacteremia and Infective Endocarditis: P. Schellong et al.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 193, doi. 10.1007/s40265-024-02135-z
- By:
- Publication type:
- Article
Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma: Liposomal Irinotecan: A Review: M. B. Brown, H. A. Blair.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 255, doi. 10.1007/s40265-024-02133-1
- By:
- Publication type:
- Article
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review: Tuberculosis Preventive Treatment: A State-of-the-Art Review: V. Chihota et al.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 127, doi. 10.1007/s40265-024-02131-3
- By:
- Publication type:
- Article
Marstacimab: First Approval: Marstacimab: First Approval: Y. N. Lamb.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 263, doi. 10.1007/s40265-024-02130-4
- By:
- Publication type:
- Article
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits: Buprenorphine Pharmacodynamics: M. Davis.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 215, doi. 10.1007/s40265-024-02128-y
- By:
- Publication type:
- Article
Aligning Large Language Models with Humans: A Comprehensive Survey of ChatGPT's Aptitude in Pharmacology: Aligning LLMs with Humans: A Survey of ChatGPT in Pharmacology: Y. Zhang et al.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 231, doi. 10.1007/s40265-024-02124-2
- By:
- Publication type:
- Article
The Future of Microbiome Therapeutics: The Future of Microbiome Therapeutics: M. Pitashny et al.
- Published in:
- Drugs, 2025, v. 85, n. 2, p. 117, doi. 10.1007/s40265-024-02107-3
- By:
- Publication type:
- Article